Publikationen 2023
| Gillessen J, Reuken PA, Hunyady PM, Reichert MC, Lothschütz L, Finkelmeier F, Nowka M, Allo G, Kütting F, Bürger M, Nierhoff D, Steffen HM, Schramm C | Evaluation of ultrasound-based surveillance success for hepatocellular carcinoma in patients at risk Results from a German multi-center retrospective cohort study; J Clin Transl Hepatol. 2023 Jun 28;11(3):626-637. |
| Gurbuz B, Guldiken N, Reuken P, Fu L, Remih K, Preisinger C, Brůha R, Leníček M, Petrtýl J, Reissing J, Aly M, Fromme M, Zhou B, Karkossa I, Schubert K, von Bergen M, Stallmach A, Bruns T, Strnad P | Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis; Hepatol Int. 2023 Jun;17(3):698-708. |
| Dannecker FD, Aschenbach R, Teichgräber U, Reuken P, Stallmach A, Zipprich A. | Erfolgreiche Interventionelle Therapie eines Patienten mit nichtzirrhotischer nichtmaligner Pfortaderthrombose mit lokaler Lyse. Z Gastroenterol. 2023 Oct;61(10):1382-1384 |
| Giszas B, Reuken PA, Katzer K, Kiehntopf M, Schmerler D, Rummler S, Stallmach A, Klink A | Immunoadsorption to treat patients with severe post-COVID syndrome.Ther Apher Dial. 2023 Aug;27(4):790-801. |
| Reuken PA, Trommer S, Besteher B, Bleidorn J, Finke K, Lemhöfer C, Stallmach A, Giszas B. | Ambulante Long/Post-COVID-Versorgung: Analyse möglicher Barrieren und Wünsche von Betroffenen an die ärztliche Betreuung [Outpatient Long/Post-COVID Care: Barriers and Desires of Affected Persons to Medical Care].Gesundheitswesen. 2023 Nov;85(11):1072-1075. |
| Quickert S, Stallmach A, Reuken PA | Folgen einer SARS-CoV-2 Infektion; Die Gastroenterologie 2023 Mar 15;18(2):136–142 |
| Lemhöfer C, Sturm C, Loudovici-Krug D, Guntenbrunner C, Bülow M, Quickert S, Reuken PA, Best N | Quality of life and ability to work of patients with Post-COVID syndrome in relation to the number of existing symptoms and the duration since infection up to 12 months: a cross-sectional study; Qual Life Res. 2023 Jul;32(7):1991-2002,DOI: 10.1007/s11136-023-03369-2 |
| Brestrich G, Angulo F, Berger FK, Hagel S, Leischker A, Lübbert C, Maechler F, Merbecks S, Minarovic N, Moisi J, von Müller L, Reuken PA, Weinke T, Yu H, Mellmann A | Epidemiology of Clostridioides difficile infections in Germany: a review from four public databases. Infect Dis Ther. 2023 Apr;12(4):1057-1072. |
| Ruhe J, Giszas B, Schlosser M, Wolf G, Reuken PA, Stallmach A | Stellenwert der Immunadsorption bei Patienten mit Post-COVID Syndrom: Fallserie eines standardisierten individuellen Heilversuchs; Dtsch Arztebl Int 2023; 120(29.30):499-500 |
| Ripoll C, Platzer S, Franken P, Aschenbach R, Wienke A, Schuhmacher U, Teichgräber U, Stallmach A, Steighardt J, Zipprich A, Liver-HERO Study Group | Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial; Trials. 2023 Apr 5;24(1):258. |
| Ripoll C, Greinert R, Reuken PA, Reichert MC, Hupfer Y, Staltner Y, Homburg F, Lammert F, Bruns T, Zipprich A | Influence of NOD2 risk variants on the prevalence of hepatic encephalopathy and association with inflammation, bacterial translocation and immune activation in cirrhosis; Liver Int. 2023 Aug;43(8):1793-1802.,PMID: 37249050 DOI: 10.1111/liv.15627 |
| Shi Y, Strobl R, Apfelbacher C, Bahmer T, Geisler R, Heuschmann P, Horn A, Hoven H, Keil T, Krawczak M, Krist L, Lemhöfer C, Lieb W, Lorenz-Depiereux B, Mikolajczyk R, Montellano FA, Reese JP, Schreiber S, Skoetz N, Störk S, Vehreschild JJ, Witzenrath M, Grill E; NAPKON Study Group (P.Reuken) | Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort; Infection. 2023 Dec;51(6):1679-1694. |
| Steinbeis F, Thibeault C, Steinbrecher S, Ahlgrimm Y, Haack IA, August D, Balzuweit B, Bellinghausen C, Berger S, Chaplinskaya-Sobol I, Cornely O, Doeblin P, Endres M, Fink C, Finke C, Frank S, Hanß S, Hartung T, Hellmuth JC, Herold S, Heuschmann P, Heyckendorf J, Heyder R, Hippenstiel S, Hoffmann W, Kelle SU, Knape P, Koehler P, Kretzler L, Leistner DM, Lienau J, Lorbeer R, Lorenz-Depiereux B, Lüttke CD, Mai K, Merle U, Meyer-Arndt LA, Miljukov O, Muenchhoff M, Müller-Plathe M, Neuhann J, Neuhauser H, Nieters A, Otte C, Pape D, Pinto RM, Pley C, Pudszuhn A, Reuken P, Rieg S, Ritter P, Rohde G, Rönnefarth M, Ruzicka M, Schaller J, Schmidt A, Schmidt S, Schwachmeyer V, Schwanitz G, Seeger W, Stahl D, Stobäus N, Stubbe HC, Suttorp N, Temmesfeld B, Thun S, Triller P, Trinkmann F, Vadasz I, Valentin H, Vehreschild M, von Kalle C, von Lilienfeld-Toal M, Weber J, Welte T, Wildberg C, Wizimirski R, Zvork S, Sander LE, Vehreschild J, Zoller T, Kurth F, Witzenrath M. | Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP), Infection, 2023 Jul 11. doi: 10.1007/s15010-023-02057-0. |
| Gremme Y, Derlien S, Katzer K, Reuken PA, Stallmach A, Lewejohann JC, Lemhöfer C | Visualizing exertional dyspnea in a post-COVID patient using electrical impedance tomography; Infection, 2023 Dec;51(6):1841-1845. doi: 10.1007/s15010-023-02062-3. |
| Lemhöfer C, Bahmer T, Baumbach P, Besteher B, Boekel A, Finke K, Katzer K, Lehmann-Pohl K, Lewejohann JC, Loudovici-Krug D, Nowka M, Puta C, Quickert S, Reuken PA, Walter M, Stallmach A | Variations and predictors of post-COVID syndrome severity in patients attending a post-COVID outpatient clinic; J Clin Med 2023, 12(12), 4013,PMID: 37373706 PMCID: PMC10298907 DOI: 10.3390/jcm12124013 |
| Martin EM, Rupprecht S, Schrenk S, Kattlun F, Utech I, Radscheidt M, Brodoehl S, Schwab M, Reuken PA, Stallmach A, Haberkost T, Finke K | A hypoarousal model of neurological post-COVID syndrome: the relation between mental fatigue, the level of central nervous activation and cognitive processing speed; J Neurol. 2023 Oct;270(10):4647-4660. |
| Franz A, Reuken PA, Guliyeva S, Stallmach A, Rose M, Boden K, Bruns T | Early Ribavirin for Hepatitis E Virus infection in patients receiving immunosuppressive therapy: A retrospective observational study; J Int Med Res. 2023 Jul;51(7):3000605231187941,PMID: 37608313 PMCID: PMC10463723 DOI: 10.1186/s12876-023-02906-0 |
| Hammersen J, Birndt S, Döhner K, Reuken P, Stallmach A, Sauerbrey P, La Rosée F, Pfirrmann M, Fabisch C, Weiss M, Träger K, Bremer H, Russo S, Illerhaus G, Drömann D, Schneider S, La Rosée P, Hochhaus A | The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial; Leukemia. 2023 Sep;37(9):1879-1886,DOI: 10.1038/s41375-023-01979-w |
| Reuken PA, Besteher B, Finke K, Fischer A, Holl A, Katzer K, Lehmann-Pohl, Lemhöfer C, Nowka M, Puta C, Walter M, Weißenborn C, Stallmach A | Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study; Eur Arch Psychiatry Clin Neurosci. 2023 Aug 16.PMID: 37587244 DOI: 10.1007/s00406-023-01661-3 |
| Kozik V, Reuken PA, Utech I, Gramlich J, Stallmach Z, Demeyere N, Rakers F, Schwab M, Stallmach A, Finke K | Characterization of neurocognitive deficits in patients with post-COVID syndrome: persistence, patients' complaints and clinical predictors; Front Psychol. 2023 Oct 17;14:1233144. |
| Martin EM, Srowig A, Utech I, Schrenk S, Kattuln F, Radscheidt M, Brodoehl S, Bublak P, Schwab M, Besteher B, Reuken PA, Stallmach A, Finke K | Persistent cognitive slowing in post-COVID patients? Longitudinal study over six months; J Neurol. 2023 epub 07 Nov 2023,PMID: 37936010 DOI: 10.1007/s00415-023-12069-3 |
| Stallmach A für das WATCH-Konsortium | Mobile Wohnortnahe Versorgung zur Steuerung der sektorübergriefenden Therapie bei Post-COVID-19 in Thüringen (WATCH) - ein durch den Innovationsfonds gefördertes Projekt; Ärzteblatt Thüringen 2023(11):47-49 |
| Manthey CF, Epple H.-J., Keller K.-M., Lübbert C, Posovszky C, Ramharter M, Reuken P, Suerbaum S, Vehreschild MJGT, Weinke T, Addo MM, Stallmach A, Lohse AW Co-Autoren: Adam R, Bogdan C, Flieger A, Frost F, Fruth A, Hagel S, Katzer K, Kittner J, Klock G, Kreuels B, Martin L, Matthes H, Menges M, Oette M, Riemer J, Rothe C, Schmiedel S, Schmitz V, Walger P | S2k-Leitlinie Gastrointestinale Infektionen der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS); Zeitschrift für Gastroenterologie, epub ahead of print |
| Ghait M, Duduskar SN, Rooney M, Häfner N, Reng L, Göhrig B, Reuken PA, Bloos F, Bauer M, Sponholz C, Bruns T, Rubio I | The non-canonical inflammasome activators Caspase-4 and Caspase-5 are differentially regulated during immunosuppression-associated organ damage; Frontiers in Immunology,PMID: 38106412 PMCID: PMC10722270 DOI: 10.3389/fimmu.2023.1239474 |
| Besteher B, Rocktäschel T, Garza AP, Machnik M, Ballez J, Helbing DL, Finke K, Reuken P, Güllmar D, Gaser C, Walter M, Opel N, Dunay IR | Cortical thickness alterations and systemic inflammation define long-COVID patients with cognitive impairment; Brain, Behavior and Immunity, Brain Behav Immun Brain Behav Immun. 2023 Nov 28:116:175-184. |
| Rao Z, Brunner E, Giszas B, Iyer-Bierhoff A, Gerstmeier J, Börner F, Jordan PM, Pace S, Meyer KPL, Hofstetter RK, Merk D, Paulenz C, Heinzel T, Grunert PC, Stallmach A, Serhan CN, Werner M, Werz O. | Glucocorticoids regulate lipid mediator networks by reciprocal modulation of 15-lipoxygenase isoforms affecting inflammation resolution, Proc Natl Acad Sci USA. 2023 Aug 29;120(35):e2302070120. |
| Scheppach MW, Rauber D, Stallhofer J, Muzalyova A, Otten V, Manzeneder C,Schwamberger T, Wanzl J, Schlottmann J, Tadic V, Probst A, Schnoy E, Römmele C,Fleischmann C, Meinikheim M, Miller S, Märkl B, Stallmach A, Palm C, Messmann H, Ebigbo A. | Detection of duodenal villous atrophy on endoscopic images using a deep learning algorithm. Gastrointest Endosc. 2023 May;97(5):911-916. doi: 10.1016/j.gie.2023.01.006. Epub 2023 Jan 13. PMID: 36646146. |
| Stallhofer J, Guse J, Kesselmeier M, Grunert PC, Lange K, Stalmann R, Eckardt V, Stallmach A. | Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease. Int J Colorectal Dis. 2023 Feb 25;38(1):54. doi:10.1007/s00384-023-04349-1. PMID: 36840779; PMCID: PMC9968255. |
| Stallmach A, Atreya R, Grunert PC, Stallhofer J, de Laffolie J, Schmidt C. | Treatment Strategies in Inflammatory Bowel Diseases. Dtsch Arztebl Int. 2023 Nov 10;120(45):768-778. doi: 10.3238/arztebl.m2023.0142. |
| Steube A, Stallhofer J, Stallmach A | Fecal microbiota transfer to treat ulcerative colitis: Medical and legal challenges, Front. Gastroenterol., 23 March 2023 Sec. Therapy in Gastroenterology Volume 2 - 2023 | https://doi.org/10.3389/fgstr.2023.1161610 |
| Deng Z-L, Pieper DH, Stallmach A, Steube A, Vital M, Reck M, Wagner-Döbler I |
Engraftment of essential functions through multiple fecal microbiota transplants in chronic antibiotic-resistant pouchitis-a case study using metatranscriptomics, Microbiome. 2023 Dec 1;11(1):269. doi: 10.1186/s40168-023-01713-9. |
| Stallhofer J, Steube A, Katzer K, Stallmach A | Microbiota-based therapeutics as new standard-of-care treatment for recurrent Clostridioides difficile infection, Visceral Medicine |
| Vehreschild MJGT, Schreiber S, von Müller L, Epple HJ, Weinke T, Manthey C, Oh J, Wahler S, Stallmach A | Trends in the epidemiology of Clostridioides difficile infection in Germany. Infection. 2023 May 10:1–8. doi: 10.1007/s15010-023-02044-5. Epub ahead of print. PMID: 37162717; PMCID: PMC10170422. |
| van Bömmel F, Stein K, Heyne R, Petersen J, Buggisch P, Berg C, Zeuzem S, Stallmach A, Sprinzl M, Schott E, Pathil-Warth A, von Arnim U, Keitel V, Lohmeyer J, Simon KG, Trautwein C, Trein A, Hüppe D, Cornberg M, Lammert F, Ingiliz P, Zachoval R, Hinrichsen H, Zipprich A, Klinker H, Schulze Zur Wiesch J, Schmiedeknecht A, Brosteanu O, Berg T | A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B. J Hepatol. 2023 May;78(5):926-936. doi: 10.1016/j.jhep.2022.12.018. Epub 2023Mar 28. PMID: 37062574 |
| Dignass A, Rath S, Kleindienst T, Stallmach A. | Editorial: If STRIDE-II is the hammer, then Crohn's disease and ulcerative colitis are not the same nails-Authors' reply,Aliment Pharmacol Ther. 2023 Sep,PMID: 37632281 DOI: 10.1111/apt.17656 |
| Refisch A, Sen ZD, Klassert TE, Busch A, Besteher B, Danyeli LV, Helbing D, Schulze-Späte U, Stallmach A, Bauer M, Panagiotou G, Jacobsen ID, Slevogt H, Opel N, Walter M. | Microbiome and immuno-metabolic dysregulation in patients with major depressive disorder with atypical clinical presentation,"Neuropharmacology. 2023 Sep 1,PMID: 37182790 DOI: 10.1016/j.neuropharm.2023.109568 |
| Quansah E, Gardey E, Ramoji A, Meyer-Zedler T, Goehrig B, Heutelbeck A, Hoeppener S, Schmitt M, Waldner M, Stallmach A, Popp J | Intestinal epithelial barrier integrity investigated by label-free techniques in ulcerative colitis patients. Sci Rep. 2023 Feb 15;13(1):2681. doi: 10.1038/s41598-023-29649-y.;PMID: 36792686; PMCID: PMC9931702. |
| Pletz MW, Steiner A, Kesselmeier M, Löffler B, Maschmann J, Stallmach A, Trommer S | Introduction of mandatory masking in health care and community: experience from Jena, German,"Infection. 2023 Oct,PMID: 37010806 PMCID: PMC10068697 DOI: 10.1007/s15010-023-02015-w |
| Stallmach A, von Müller L, Storr M, Link A, Konturek PC, Solbach PC, Weiss KH, Wahler S, Vehreschild | [Fecal Microbiota Transfer (FMT) in Germany - Status and Perspective, Z Gastroenterol. 2023 May 15. doi: 10.1055/a-2075-2725. Online ahead of print,PMID: 37187187 German. |
| Bae H, Rodewald M, Meyer-Zedler T, Bocklitz TW, Matz G, Messerschmidt B, Press AT, Bauer M, Guntinas-Lichius O, Stallmach A, Schmitt M, Popp J. | Feasibility studies of multimodal nonlinear endoscopy using multicore fiber bundles for remote scanning from tissue sections to bulk organs, Sci Rep. Aug 23;13(1):13779. 10.1038/s41598-023-40944-6 |
| Ripoll C, Platzer S, Franken P, Aschenbach R, Wienke A, Schuhmacher U, Teichgräber U, Stallmach A, Steighardt J, Zipprich A | Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial, Liver-HERO Study Group.","Trials. 2023 Apr 5,PMID: 37020315 PMCID: PMC10077612 DOI: 10.1186/s13063-023-07261-9 |
| Uhlir V, Stallmach A, Grunert PC | Fatigue in patients with inflammatory bowel disease-strongly influenced by depression and not identifiable through laboratory testing: a cross-sectional survey study,"BMC Gastroenterol. 2023 Aug 22;23(1):288. |
| Bahrs C, Weis S, Kesselmeier M, Ankert J, Hagel S, Beier S, Maschmann J, Stallmach A, Steiner A, Bauer M, Behringer W, Baier M, Richert C, Zepf F, Walter M, Scherag A, Kiehntopf M, Löffler B, Pletz MW | Non-patient-related SARS-CoV-2 exposure from colleagues and household members poses the highest infection risk for hospital employees in a German university hospital: follow-up of the prospective Co-HCW seroprevalence study. Infection. 2023 Feb 15:1–9. doi:10.1007/s15010-023-01995-z. Epub ahead of print. PMID: 36788173; PMCID:PMC9928590. |
| Dignass A, Rath S, Kleindienst T, Stallmach A. | Letter: The importance of histological assessment-a further stride in STRIDE. Authors' reply, Aliment Pharmacol Ther. 2023 Dec;58(11-12):1246-1247 |
| Rudler M, Hernández-Gea V, Procopet BD, Giráldez A, Amitrano L, Villanueva C, Ibañez L, Silva-Junior G, Genesca J, Bureau C, Trebicka J, Bañares R, Krag A, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Noronha Ferreira C, Canete N, Rodríguez M, Ferlitsch A, Mundi JL, Gronbaek H, Hernandez-Guerra M, Sassatelli R, Dell'era A, Senzolo M, Abraldes JG, Romero-Gómez M, Zipprich A, Casas M, Masnou H, Larrue H, Primignani M, Nevens F, Calleja JL, Schwarzer R, Jansen C, Robic MA, Conejo I, Martínez Gonzalez J, Catalina MV, Albillos A, Alvarado E, Guardascione MA, Mallet M, Tripon S, Casanovas G, Bosch J, Garcia-Pagan JC, Thabut D | Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding. Gut. 2023 Apr;72(4):749-758. doi: 10.1136/gutjnl-2022-326975. Epub 2022 Sep 9. |
| Tautenhahn HM, Kindler EM, Volmer K, Zipprich A, Settmacher U | [Liver transplantation in aged patients]Chirurgie (Heidelb). 2023 Jan;94(1):28-35. doi: 10.1007/s00104-022-01776-8. Epub 2023 Jan 12 |
| Ripoll C, Bleidorn J, Zipprich A | SEAL: Why was this approach not effective? J Hepatol. 2023 Jan;78(1):e26-e27. doi: 10.1016/j.jhep.2022.07.031. Epub 2022 Aug 17. |
| Ripoll C, Zipprich A | Spleen stiffness to identify clinically significant portal hypertension, Lancet Gastroenterol Hepatol. 2023 Sep;8(9):775-776. doi: 10.1016/S2468-1253(23)00189-9. Epub 2023 Jul 18. |
| Villagrasa A, Hernández-Gea V, Bataller R, Giráldez Á, Procopet B, Amitrano L, Villanueva C, Thabut D, Ibañez-Samaniego L, Albillos A, Bureau C, Trebicka J, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Ferreira CN, Cañete N, Rodríguez M, Ferlitsch A, Mundi JL, Gronbaek H, Hernández-Guerra M, Sassatelli R, Dell'Era A, Senzolo M, Abraldes JG, Zipprich A, Casas M, Masnou H, Primignani M, Krag A, Silva-Junior G, Romero-Gómez M, Tantau M, Guardascione MA, Alvarado E, Rudler M, Bañares R, Martinez J, Robic MA, Jansen C, Calleja JL, Nevens F, Bosch J, Ventura-Cots M, García-Pagan JC, Genescà J | Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode., International Variceal Bleeding Observational Study Group, Liver Int. 2023 Jul;43(7):1548-1557. doi: 10.1111/liv.15606. Epub 2023 May 15. |
| Gairing SJ, Mangini C, Zarantonello L, Gioia S, Nielsen EJ, Danneberg S, Gabriel M, Ehrenbauer AF, Bloom PP, Ripoll C, Sultanik P, Galle PR, Labenz J, Thabut D, Zipprich A, Lok AS, Weissenborn K, Marquardt JU, Lauridsen MM, Nardelli S, Montagnese S, Labenz C. | Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter Study. Am J Gastroenterol. 2023 Dec 1;118(12):2191-2200. doi: 10.14309/ajg.0000000000002251. Epub 2023 Mar 20. |
| Gu W, Zeleke Y, Hortlik H, Schaaf L, Uschner FE, Schulz M, Tischendorf M, Peiffer KH, Brol MJ, Kimmann M, Vogl T, Köhler M, Meyer C, Gerbes A, Rössle M, Laleman W, Zipprich A, Steib C, Praktiknjo M, Trebicka J | Use and outcome of TIPS in hospitalized patients in Germany: A Nationwide study (2007-2018). Hepatol Commun. 2023 Sep 15;7(10):e0237. doi: 10.1097/HC9.0000000000000237. eCollection 2023 Oct 1. |
| Greinert R, Zipprich A, Casper M, Reichert MC, Lammert F, Ripoll C | Presence of NOD2 mutations is not associated with hepatic or systemic hemodynamic abnormalities of cirrhosis, Dig Liver Dis. 2023 Oct, 55(10):1362-1367. doi: 10.1016/j.dld.2023.05.016. Epub 2023 Jun 13 |
| Balcar L, Mandorfer M, Hernández-Gea V, Procopet B, Meyer EL, Giráldez Á, Amitrano L, Villanueva C, Thabut D, Samaniego LI, Silva-Junior G, Martinez J, Genescà J, Bureau C, Trebicka J, Herrera EL, Laleman W, Palazón Azorín JM, Alonso JC, Gluud LL, Ferreira CN, Cañete N, Rodríguez M, Ferlitsch A, Mundi JL, Grønbæk H, Hernandez Guerra MN, Sassatelli R, Dell'Era A, Senzolo M, Abraldes JG, Romero-Gómez M, Zipprich A, Casas M, Masnou H, Primignani M, Krag A, Nevens F, Calleja JL, Jansen C, Catalina MV, Albillos A, Rudler M, Tapias EA, Guardascione MA, Tantau M, Schwarzer R, Reiberger T, Laursen SB, Lopez-Gomez M, Cachero A, Ferrarese A, Ripoll C, La Mura V, Bosch J, García-Pagán JC | Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding, International Variceal Bleeding Observational Study Group by the Baveno Cooperation: an EASL consortium.","J Hepatol. 2023 Oct 16:S0168-8278(23)05171-1. doi: 10.1016/j.jhep.2023.10.007. Online ahead of print.","Balcar L","J |
| González-Mansilla A, Castellote-Domínguez I, Fernández-Quintanilla S, Martínez-Legazpi P, Ripoll C, Vega Catalina M, Rincón D, Fernández-Avilés F, Bañares R, Bermejo J. | Prognostic implications of systolic function in patients with cirrhosis, Gastroenterol Hepatol. 2023 Jun-Jul, PMID: 36272551 DOI: 10.1016/j.gastrohep.2022.10.011 |
| Gairing SJ, Mangini C, Zarantonello L, Gioia S, Nielsen EJ, Danneberg S, Gabriel M, Ehrenbauer AF, Bloom PP, Ripoll C, Sultanik P, Galle PR, Labenz J, Thabut D, Zipprich A, Lok AS, Weissenborn K, Marquardt JU, Lauridsen MM, Nardelli S, Montagnese S, Labenz C. | Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter Study,Am J Gastroenterol. 2023 Dec 1,PMID: 36940426 DOI: 10.14309/ajg.0000000000002251 Abstract |
| Greinert R, Greinert D, Eger AL, Ripoll C, Girndt M | Subclinical cognitive impairment in chronic kidney disease is associated with frailty and reduced quality of life, Nephrol Dial Transplant. 2023 May 4,38(5):1151-1157. doi: 10.1093/ndt/gfac303 |
| Gardey E, Cseresnyes Z, Sobotta FH, Haziri D, Grunert PC, Kuchenbrod MT, Gruschwitz FV, Hoeppener S, SchumannM, Gaßler N, Figge MT, Stallmach A, Brendel JC | Selective uptake into inflamed human intestinal tissue and immune cell targeting by wormlike polymer micelles Selective uptake into inflamed human intestinal tissue and immune cell targeting by wormlike polymer micelles Small. 2023 Dec 18:e2306482. doi: 10.1002/smll.202306482. |
| Quansah E, Gardey E, Ramoji A, Meyer-Zedler T, Goehrig B, Heutelbeck A, Hoeppener S, Schmitt M, Waldner M, Stallmach A, Popp J | Intestinal epithelial barrier integrity investigated by label-free techniques in ulcerative colitis patients. Sci Rep 2023, 13, 2681 *Shared co-first authorship,PMID: 36792686 PMCID: PMC9931702 DOI: 10.1038/s41598-023-29649-y |
| Kaplan DE, Bosch J, Ripoll C, Thiele M, Fortune BE, Simonetto DA, Garcia-Tsao G. | AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis Hepatology 2023; Oct 23. doi: 10.1097/HEP.0000000000000647 |
| Gu W, Zeleke Y, Hortlik H, Schaaf L, Uschner FE, Schulz M, Tischendorf M, Peiffer KH, Brol MJ, Kimmann M, Vogl T, Köhler M, Meyer C, Gerbes A, Rössle M, Laleman W, Zipprich A, Steib C, Praktiknjo M, Trebicka J; German TIPS Working Group. | Use and outcome of TIPS in hospitalized patients in Germany: A Nationwide study (2007-2018),PMID: 37708430 PMCID: PMC10503680 DOI: 10.1097/HC9.0000000000000237 |
| Ripoll C, Platzer S, Franken P, Aschenbach R, Wienke A, Schuhmacher U, Teichgräber U, Stallmach A, Steighardt J, Zipprich A; Liver-HERO Study Group. | Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial. Trials. 2023 Apr 5;24(1):258. doi: 10.1186/s13063-023-07261-9. |
| Weiss E, de la Peña-Ramirez C, Aguilar F, Lozano JJ, Sánchez-Garrido C, Sierra P, Martin PI, Diaz JM, Fenaille F, Castelli FA, Gustot T, Laleman W, Albillos A, Alessandria C, Domenicali M, Caraceni P, Piano S, Saliba F, Zeuzem S, Gerbes AL, Wendon JA, Jansen C, Gu W, Papp M, Mookerjee R, Gambino CG, Jiménez C, Giovo I, Zaccherini G, Merli M, Putignano A, Uschner FE, Berg T, Bruns T, Trautwein C, Zipprich A, Bañares R, Presa J, Genesca J, Vargas V, Fernández J, Bernardi M, Angeli P, Jalan R, Claria J, Junot C, Moreau R, Trebicka J, Arroyo V | Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)Gut. 2023 Aug;72(8):1581-1591. doi: 10.1136/gutjnl-2022-328708. Epub 2023 Feb 14. PMID: 36788015 |
| van Bömmel F, Stein K, Heyne R, Petersen J, Buggisch P, Berg C, Zeuzem S, Stallmach A, Sprinzl M, Schott E, Pathil-Warth A, von Arnim U, Keitel V, Lohmeyer J, Simon KG, Trautwein C, Trein A, Hüppe D, Cornberg M, Lammert F, Ingiliz P, Zachoval R, Hinrichsen H, Zipprich A, Klinker H, Schulze Zur Wiesch J, Schmiedeknecht A, Brosteanu O, Berg T | A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis BJ Hepatol. 2023 May;78(5):926-936. doi: 10.1016/j.jhep.2022.12.018. Epub 2023 Mar 28. |
| Lange CM, Trebicka J, Gerbes A, Canbay A, Geier A, Merle U, Peck-Radosavljevic M, Tacke F, Vogelmann T, Theis S, Heinze H, Zipprich A. | Limited access to liver transplantation and TIPS despite high mortality, healthcare resource use and costs of cirrhosis in GermanyLiver Int. 2023 Nov;43(11):2503-2512. doi: 10.1111/liv.15688. Epub 2023 Aug 21. PMID: 37602977 |
| D'Amico G, Zipprich A, Villanueva C, Sordà JA, Morillas RM, Garcovich M, García Retortillo M, Martinez J, Calès P, D'Amico M, Dollinger M, García-Guix M, Gonzalez Ballerga E, Tsochatzis E, Cirera I, Albillos A, Roquin G, Pasta L, Colomo A, Daruich J, Canete N, Boursier J, Dallio M, Gasbarrini A, Iacobellis A, Gobbo G, Merli M, Federico A, Svegliati Baroni G, Pozzoni P, Addario L, Chessa L, Ridola L, Garcia-Tsao G. | Further decompensation in cirrhosis. Results of a large multicenter cohort study supporting Baveno VII statements. Hepatology. 2023 Nov 2. doi: 10.1097/HEP.0000000000000652. ,PMID: 37916970 |
| Csernalabics B, Marinescu MS, Maurer L, Kelsch L, Werner J, Baumann K, Zoldan K, Panning M, Reuken P, Bruns T, Bengsch B, Neumann-Haefelin C, Hofmann M, Thimme R, Loan Dao Thi V, Boettler T | Efficient formation and maintenance of humoral and CD4 T cell immunity targeting the viral capsid in acute-resolving hepatitis E infection. J Hepatol 2023 PMID: 38154741 DOI: 10.1016/j.jhep.2023.12.016 |
| Giszas B, Trommer S, Schüßler N, Rodewald A, Besteher B, Bleidorn J, Dickmann P, Finke K, Katzer K, Lehmann-Pohl K, Lemhöfer C, Pletz MW, Puta C, Quickert S, Walter M, Stallmach A, Reuken PA. | Post-COVID-19 condition is not only a question of persistent symptoms: structured screening including health- related quality of life reveals two separate clusters of post-COVID. Infection.2023 Apr;51(2):365-377. doi: 10.1007/s15010-022-01886-9. Epub 2022 Jul 22. PMID:35869353; PMCID: PMC9307219. |
| Stallmach A, Katzer K, Besteher B, Finke K, Giszas B, Gremme Y, Abou HamdanR, Lehmann-Pohl K, Legen M, Lewejohann JC, Machnik M, Moshmosh Alsabbagh M,Nardini L, Puta C, Stallmach Z, Reuken PA. | Mobile primary healthcare for post-COVID patients in rural areas: a proof-of-concept study. Infection. 2023 Apr;51(2):337-345. doi: 10.1007/s15010-022-01881-0. Epub 2022 Jul 13. PMID:35831582; PMCID: PMC9281342. |
| Giszas B, Ruhe J, Schlosser M, Reuken PA, John-Kroegel U, Stallmach A, Wolf G. | Graft function and health status in renal transplant recipients hospitalized for COVID-19: a single center case series. J Nephrol. 2023 Apr;36(3):613-615.doi: 10.1007/s40620-022-01451-5. Epub 2022 Sep 5. PMID: 36063289; PMCID:PMC9442566. |
| Dignass A, Rath S, Kleindienst T, Stallmach A. | Review article: Translating STRIDE-II into clinical reality - Opportunities and challenges,Aliment Pharmacol Ther. 2023 Sep;58(5):492-502. doi: 10.1111/apt.17622. Epub 2023 Jun 29., PMID: 37382397 |
| Banz M, Stallmach A, Gaßler N, Schulze PC, Fritzenwanger M, Cornely O, Kurzai O, Pletz MW. | Fatal pulmonary hemorrhage, pneumothorax and skin necrosis caused by IRIS to an Aspergillus flavus infection in a young patient with metamizole associated agranulocytosis, • PMID: 38133714 •DOI: 10.1007/s15010-023-02149-x |
| Kucharzik T, Dignass A, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengiesser K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. | Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009Z Gastroenterol. 2023 Aug;61(8):1046-1134. |
| Feagan BG, Sands BE, Sandborn WJ, Germinaro M, Vetter M, Shao J, Sheng S, Johanns J, Panés J; VEGA Study Group.: Alexander Tkachev, Dilara Kalimullina, Robert Petryka, Marina Osipenko, Nataliia Tsarynna, Leonid Bilianskyi, Dariusz Kleczkowski, Andrii Yurkiv, Marek Woynarowski, Orest Abrahamovych, Olha Ivanishyn, Grazyna Rydzewska, Jaroslaw Kierkus, Elina Petrova, Olga Vasilevskaya, Halyna Afanasieva, Carlos Francesconi, Jaroslaw Leszczyszyn, Elena Bunkova, Dmitry Platonov, Olena Datsenko, Oleksii Gridnyev, Ihor Hospodarsky, Liudmyla Prystupa, Mykola Stanislavchuk, Anatoly Pershko, Oksana Shchukina, Vladimir Simanenkov, Oleksandr Golovchenko, William Holderman, Juan Lasa, Jakob Begun, Maria de Lourdes de Abreu Ferrari, Pedro Lopez, Andrey Obrezan, Shiraz Farooq, Felix Tiongco, Abel Novillo, Emiliano Tron, Finlay Macrae, Rupert Leong, Ligia Yukie Sassaki, Cyrla Zaltman, Roberto Kaiser Junior, Andreas Stallmach, Jochen Klaus, Manuel Martinez, Azalia Ruiz, Rustem Abdulkhakov, Vishvinder Sharma, Louis Korman, James Lord, Bhaktasharan Patel, Timothy Ritter | Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial. Lancet Gastroenterol Hepatol . 2023 Apr;8(4):307-320. |
| Travis S, Silverberg MS, Danese S, Gionchetti P, Löwenberg M, Jairath V, Feagan BG, Bressler B, Ferrante M, Hart A, Lindner D, Escher A, Jones S, Shen B; EARNEST Study Group: Marc Ferrante, Brian Bressler, Mark Silverberg, Richmond Sy, Cyrielle Gilletta de Saint Joseph, Laurent Peyrin-Biroulet, Laurent Siproudhis, Daniel Baumgart, Andreas Fischer, Tanja Kuehbacher, Andreas Stallmach, Alessandro Armuzzi, Silvio Danese, Paolo Gionchetti, Edoardo Savarino, Mark Löwenberg, Marie Pierik, Guillermo Bastida Paz, Ailsa Hart, Gareth Parkes, Simon Travis, Dawn Beaulieu, Robin Dalal, Sushila Dalal, John Hanson, Hans Herfarth, Darrell Pardi, Jessica Philpott, Timothy Ritter, Bo Shen, John Valentine, Byron Vaughn, Eugene Yen | Vedolizumab for the Treatment of Chronic Pouchitis.N Engl J Med. 2023 Mar 30;388(13):1191-1200 |
| Louis E, Resche-Rigon M, Laharie D, Satsangi J, Ding N, Siegmund B, D'Haens G, Picon L, Bossuyt P, Vuitton L, Irving P, Viennot S, Lamb CA, Pollok R, Baert F, Nachury M, Fumery M, Gilletta C, Almer S, Ben-Horin S, Bouhnik Y, Colombel JF, Hertervig E; GETAID and the SPARE-Biocycle research group: Jane Andrews, Miles Sparrow, Rupert Leong, Susan Connor, Graham Radforth-Smith, Peter De Cruz, Jan Preiss, Andreas Stallmach, Thomas Liceni, Olaf Grip, Jonas Halfvarson, Dharmaraj Durai, Fraser Cummings, Christian Seilinger, Miles Parkes, James Lindsay, Guy Lambrecht, Philippe Van Hootegem, Jean-François Rahier, Marie Dewitte, Xavier Hebuterne, Elise Chanteloup, Romain Altwegg, Stephane Nancey, Guillaume Bouguen, Guillaume Pineton de Chambrun, Floriant Poullenot, Xavier Roblin | Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trialLancet Gastroenterol Hepatol. 2023 Mar;8(3):215-227 |
| Sbirkov Y, Schenk T, Kwok C, Stengel S, Brown R, Brown G, Chesler L, Zelent A, Fuchter MJ, Petrie K. | Dual inhibition of EZH2 and G9A/GLP histone methyltransferases by HKMTI-1-005 promotes differentiation of acute myeloid leukemia cells. Front Cell Dev Biol. 2023 Mar 23;11:1076458. doi: 10.3389/fcell.2023.1076458. |
| Müller-Schilling M, Stallmach A | Covid-19 und Gastroenterologie; Die Gastroenterologie 2023 Feb 16;18:78-83–142 |
| Teich N, Stallmach A | Covid-19 und chronisch-entzündliche Darmerkrankungen; Die Gastroenterologie 2023 Jan 30;18:100-106 |
| Stallmach A, Pletz M | Welchen Einfluss hat die SARS-CoV-2-Impfung auf die Gefahr, an Post-Covid zu erkranken, und wie hoch ist das Risiko für ein Post-VAC-Syndrom?; Deutsches Ärzteblatt: Ausgabe 9/2023: 34-36 |
Publikationen 2022
| Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004. Z Gastroenterol. 2022 Mar;60(3):332-418. German. doi: 10.1055/a-1713-3941. Epub 2022 Mar 9. PMID: 35263784. | Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignaß A, Ehehalt R, Germer C, Grunert PC, Helwig U, Herrlinger K, Kienle P, Kreis ME, Kucharzik T, Langhorst J, Maaser C, Ockenga J, Ott C, Siegmund B, Zeißig S, Stallmach A; Collaborators |
| Die wichtigsten Änderungen der aktualisierten S3-Leitlinie Morbus Crohn der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) im Überblick. Z Gastroenterol. 2022 Mar;60(3):295-296. German. doi: 10.1055/a-1713-4177. Epub 2022 Mar 9. PMID: 35263781. | Stallmach A, Sturm A. |
| Leitlinienreport der aktualisierten S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004. Z Gastroenterol. 2022 Mar;60(3):e228-e235. German. doi: 10.1055/a-1713-4138. Epub 2022 Mar 9. PMID: 35263779 | Lorenz P, Stallmach A, Sturm A, Jansen PL. |
| Bakterielle hepatobiliäre Infektione: Erregerspektrum, antimikrobielle Resistenzentwicklung und aktuelle Therapiekonzepte. Internist (Berl). 2022 Apr;63(4):349-366. German. doi: 10.1007/s00108-022-01277-0. Epub 2022 Mar 3. PMID: 35238985. | Bruns T, Stallmach A |
| Detection of Liver Dysfunction Using a Wearable Electronic Nose System Based on Semiconductor Metal Oxide Sensors. Biosensors (Basel). 2022 Jan 26;12(2):70. doi22.04.2022 10.3390/bios12020070 | Voss A, Schroeder R, Schulz S, Haueisen J, Vogler S, Horn P, Stallmach A, Reuken P. |
| Transfer of Frozen Encapsulated multi-donor Stool filtrate for active ulcerative Colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial. Trials. 2022 Feb 22;23(1):173. doi: 10.1186/s13063-022-06095-1. PMID: 35193638; PMCID: PMC8861997. | Stallmach A, Grunert P, Stallhofer J, Löffler B, Baier M, Rödel J, Kiehntopf M, Neugebauer S, Pieper DH, Junca H, Tannapfel A, Merkel U, Schumacher U, Breternitz-Gruhne M, Heller T, Schauer A, Hartmann M, Steube A |
| Meta-analysis of aspirin-guided therapy of colorectal cancer. J Cancer Res Clin Oncol. 2022 Feb 16. doi:10.1007/s00432-022-03942-1. Epub ahead of print. PMID: 35171329. | Mädge JC, Stallmach A, Kleebusch L, Schlattmann P |
| Chronisch-entzündliche Darmerkrankungen in der COVID-Pandemie: Manifestationen und Management [Inflammatory bowel disease during the COVID-19 pandemic: manifestations and management]. Z Gastroenterol. 2022 Feb 11. German. doi: 10.1055/a-1744-6697. Epub ahead of print. PMID: 35148564. |
Stallmach A, Reuken PA, Grunert P, Teich N. |
| Real-world effectiveness of piperacillin/tazobactam with and without linezolid for spontaneous bacterial peritonitis. Dig Dis. 2022 Jan 31. doi: 10.1159/000522259. Epub ahead of print. PMID: 35100589. | Quickert S, Würstle S, Reuken PA, Hagel S, Schneider J, Schmid RM, Neugebauer S, Stallmach A, Bruns T. |
| Clinical predictors for a complicated course of disease in an inception cohort of patients with ulcerative colitis: results from the prospective, observational EPICOL study. Int J Colorectal Dis. 2022 Feb;37(2):485-493. doi: 10.1007/s00384-022-04098-7. Epub 2022 Jan 27. PMID: 35084534; PMCID: PMC8803753 | Schmidt C, Bokemeyer B, Lügering A, Bettenworth D, Teich N, Fischer I, Hammer L, Kolterer S, Rath S, Stallmach A; EPICOL Study Group |
| ROS-Sensitive Polymer Micelles for Selective Degradation in Primary Human Monocytes from Patients with Active IBD. Macromol Biosci. 2022 Apr;22(4):e2100482. doi: 10.1002/mabi.202100482. Epub 2022 Feb 3. PMID: 35068059. |
Gardey E, Sobotta FH, Quickert S, Bruns T, Brendel JC, Stallmach A. |
| SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease. Z Gastroenterol. 2022 Jan;60(1):77-80. English. doi: 10.1055/a-1710-3861. Epub 2022 Jan 18. PMID: 35042256. | Elkharsawi A, Arnim UV, Schmelz R, Sander C, Stallmach A, Teich N, Walldorf J, Reuken PA. |
| Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression. Clin Transl Gastroenterol. 2022 Jan 13;13(1):e00450. doi: 10.14309/ctg.0000000000000450. PMID: 35029158; PMCID: PMC8806373. | Stallhofer J, Veith L, Diegelmann J, Probst P, Brand S, Schnitzler F, Olszak T, Török H, Mayerle J, Stallmach A, Beigel F |
| Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation? Infection. 2022 Jan 7:1–9. doi: 10.1007/s15010-021-01733-3. Epub ahead of print. PMID: 34997542; PMCID: PMC8741139. | Stallmach A, Kesselmeier M, Bauer M, Gramlich J, Finke K, Fischer A, Fleischmann-Struzek C, Heutelbeck A, Katzer K, Mutschke S, Pletz MW, Quickert S, Reinhart K, Stallmach Z, Walter M, Scherag A, Reuken PA |
| T Cell Response After SARS-CoV-2 Vaccination in Immunocompromised Patients with Inflammatory Bowel Disease. J Crohns Colitis. 2022 Feb 23;16(2):251-258. doi: 10.1093/ecco-jcc/jjab147. PMID: 34379729; PMCID: PMC8385945. |
Reuken PA, Andreas N, Grunert PC, Glöckner S, Kamradt T, Stallmach A. |
| Prospective surveillance study in a 1,400-bed university hospital: COVID-19 exposure at home was the main risk factor for SARS-CoV-2 point seroprevalence among hospital staff. Transbound Emerg Dis. 2022 Mar;69(2):720-730. doi: 10.1111/tbed.14041. Epub 2021 Mar 9. PMID: 33605549; PMCID: PMC8014017. |
Bahrs C, Kimmig A, Weis S, Ankert J, Hagel S, Maschmann J, Stallmach A, Steiner A, Bauer M, Behringer W, Baier M, Kesselmeier M, Richert C, Zepf F, Walter M, Scherag A, Kiehntopf M, Löffler B, Pletz MW. |
| Soluble mannose receptor CD206 and von Willebrand Factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis. Journal of Intensive Care, in press | Philipp Reuken, Jonathan Brozat, Stefanie Quickert, Oluwatomi Ibidapo-Obe, Johanna Reißing, Anika Franz, Sven Stengel, Ulf Teichgräber, Michael Kiehntopf, Christian Trautwein, Andreas Stallmach, Alexander Koch, Tony Bruns |
| Apparative Diagnostik bei Post-COVID. Information und Nutzen für therapierelevante Befunde. Deutsches Ärzteblatt, in press | Philipp A. Reuken, Marcus Franz, Benjamin Giszas, Jutta Bleidorn, Tobias Rachow, Andreas Stallmach |
| Mobile Primary Healthcare for post-COVID Patients in Rural Areas: a Proof-of-Concept Study. Infection, in press | A. Stallmach, K. Katzer, B. Besteher, K. Finke, B. Giszas, Y. Gremme, R. A. Hamdan, K. Lehmann-Pohl, M. Legen, J.-C. Lewejohann, M. Machnik, M. Moshmosh Alsabbagh, L. Nardini, C. Puta, Z. Stallmach, P. A. Reuken |
| COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry. United European Gastroenterol J. 2022 May;10(4):409-424. doi: 10.1002/ueg2.12232 | Brozat JF, Hanses F, Haelberger M, Stecher M, Dreher M, Tometten L, Ruethrich MM, Vehreschild JJ, Trautwein C, Borgmann S, Vehreschild MJGT, Jakob CEM, Stallmach A, Wille K, Hellwig K, Isberner N, Reuken PA, Geisler F, Nattermann J, Bruns T; LEOSS study group. |
| Post-COVID-19 condition is not only a question of persistent symptoms – structured screening including health related quality of life reveals two separate clusters of post-COVID, Infection, in press | Giszas B, Trommer S, Schüßler N, Rodewald A, Besteher B, Bleidorn J, Dickmann P, Finke K, Katzer K, Lehmann-Pohl K, Lemhöfer C, Pletz M, Puta C, Quickert S, Walter M, Stallmach A, Reuken PA |
| Monoclonal SARS-CoV-2 Antibodies in Pregnancy-a Case Series. Dtsch Arztebl Int. 2022 Feb 18;119(7):113-114 | Zöllkau J, Reuken PA, Schleußner E, Groten T. |
| The Patient's Point of View: COVID-19 and Neuroendocrine Tumor Disease. Cancers (Basel). 2022 Jan 26;14(3):613. doi: 10.3390/cancers14030613 | Krug S, Khosravian M, Weissbach J, George K, Damm M, Garbe J, Walldorf J, Reuken PA, Amin T, Siebenhüner A, Rosendahl J, Gress TM, Michl P, Schrader J, Rinke A |
| Baveno VII - Renewing consensus in portal hypertension. J Hepatol 2022 Apr;76(4):959-974. | de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; for the Baveno VII Faculty. |
| EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J Hepatol . 2022 May;76(5):1151-1184. doi: 10.1016/j.jhep.2021.09.003 | Erica Villa, Marcello Bianchini, Annabel Blasi, Alban Denys, Edoardo G Giannini, Andrea de Gottardi, Ton Lisman, Emmanuelle de Raucourt, Cristina Ripoll, Pierre-Emmanuel Rautou |
| Mineralocorticoid receptors in non-alcoholic fatty liver disease. Br J Pharmacol 2022 Jul;179(13):3165-3177. doi: 10.1111/bph.15784 | Schreier B, Zipprich A, Uhlenhaut H, Gekle M. |
| Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndromeGut. 2022 Aug;71(8):1567-1576. doi: 10.1136/gutjnl-2021-325181 | Bojarski C, Tangermann P, Barmeyer C, Buchkremer J, Kiesslich R, Ellrichmann M, Schreiber S, Schmidt C, Stallmach A, Roehle R, Loddenkemper C, Daum S, Siegmund B, Schumann M, Ullrich R |
| Mobile Post-COVID Units: A Win-Win Proposition? Journal of Health Care Communications, in press | Reuken, PA, Stallmach A |
| Infliximab in the treatment of patients with severe COVID-19 (INFLIXCOVID): protocol for a randomised, controlled, multicentre, open label phase II clinical study. Trials, in press | Sina M Coldewey; Charles Neu; Frank Bloos; Philipp Baumbach; Ulrike Schumacher; Michael Bauer; Philipp Reuken; Andreas Stallmach |
| Graft function and health status in renal transplant recipients hospitalized for COVID-19: a single center case series. J Nephrol 2022 | Giszas B*, Ruhe J*, Schlosser M, Reuken PA, John-Kroegel U, Stallmach A*, Wolf G* |
| Role of IQ Motif-Containing GTPase-Activating Proteins in Hepatocellular Carcinoma. Front Oncol. 2022 Jun 16;12:920652. doi: 10.3389/fonc.2022.920652. eCollection 2022 | Dai Q, Ain Q, Rooney M, Song F, Zipprich A. |
| Addendum zur S2k-Leitlinie Gastrointestinale Blutungen der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Z Gastroenterol. 2022 Jul;60(7):1139-1145. doi: 10.1055/a-1788-3501. Epub 2022 Jul 11 | Götz M, Biecker E, Dechêne A, Schilling D, Zipprich A, Trebicka J |
| The liver in sepsis: molecular mechanism of liver failure and their potential for clinical translation. Mol Med. 2022 Jul 30;28(1):84. doi: 10.1186/s10020-022-00510-8 | Beyer D, Hoff J, Sommerfeld O, Zipprich A, Gaßler N, Press AT |
| SEAL: why was this approach not effective? J Hepatol. 2022 Aug 16;S0168-8278(22)02997-X. doi: 10.1016/j.jhep.2022.07.031. Online ahead of print | Ripoll C, Bleidorn J, Zipprich A. |
| Increased accuracy of FNA - based cytological diagnosis of pancreatic lesions by use of an ethanol-based fixative system: a STROBE compliant study. Medicine.(Baltimore) 2022 Sep 9;101(36):e30449. doi: 10.1097/MD.0000000000030449.PMID: 36086724 | M. Bürger, A. Besser, I. Petersen, A. Stallmach, C. Schmidt |
| Adenoma detection rate using narrow-band imaging is inferior to high-definition white light colonoscopy in screening and surveillance colonoscopies in daily clinical care: A randomized controlled trial. Medicine (Baltimore). 2022 Aug 12;101(32):e29858. doi: 10.1097/MD.0000000000029858, PMID: 3596007 | Bürger M, Weber M, Petersen I, Stallmach A, Schmidt C |
| Fäkaler Mikrobiomtransfer – Indikationen, Risiken und Chancen. Inn Med (Heidelb) 2022 Oct;63(10):1036-1042. doi: 10.1007/s00108-022-01399-5. Epub 2022 Sep 2. | Stallmach A, Steube A, Stallhofer J, Grunert PC, Merkel U, Hartmann M |
| Gastrointestinal Infections and the Risk of Inflammatory Bowel Disease in Twins and Siblings: Evidence Against the Hygiene Hypothesis. Dig Dis Sci.2022 Oct;67(10):4960-4961. doi: 10.1007/s10620-022-07670-x. Epub 2022 Aug 24. PMID: 36002673 PMCID: PMC9515034 | Teich N, Stallmach A, Bruns T |
| SER-109: oral microbiome therapy for recurrent Clostridioides difficile infections : SER-109 versus Placebo in the Treatment of Adults with Recurrent Clostridium Difficile Infection (ECOSPOR III). Inn Med (Heidelb).2022 Jul;63(7):805-807. doi: 10.1007/s00108-022-01346-4. Epub 2022 May 17. PMID: 35925263 | Stallmach A, Nitschmann S |
| Larger gray matter volumes in neuropsychiatric long-COVID syndrome. Psychiatry Research,2022 Nov;317:114836. doi: 10.1016/j.psychres.2022.114836. Epub 2022 Sep 6. PMID: 36087363 PMCID: PMC9444315 | B. Besteher, M. Machnik, M. Troll, A. Toepffer, A. Zerekidze, T. Rocktäschel, C. Heller, Z. Kikinis, St. Brodoehl, K. Finke, P. A, Reuken, N. Opel, A. Stallmach, C. Gaser, M. Walter. |
| Electrical impedance tomography (EIT) in a patient suffering from post-Covid syndrome with dyspnea: a Case Report. Diagnostics (Basel), 2022 Sep 21;12(10):2284. doi: 10.3390/diagnostics12102284. PMID: 36291973 PMCID: PMC9599970 | K. Katzer , Y. Gremme, M. Moshmosh Alsabbagh, A. Stallmach, P. Reuken, J.-C. Lewejohann |
| Long COVID: a narrative review of the clinical aftermaths of COVID-19 with a focus on the putative pathophysiology and aspects of physical activity. Oxford Open Immunology,Immunology, 2022, 3(1), iqac006 und doi 10.1093/oxfimm/iqac006 | S. Haunhorst, W. Bloch, H. Wagner, C. Ellert, K. Krüger, D. C. Vilser, K. Finke, P. Reuken, M. W. Pletz, A. Stallmach, C. Puta |
| Disease recurrence in patients with Crohn’s disease after biologic therapy or surgery: a meta-analysis.Int J Colorectal Dis 2022 Oct;37(10):2185-2195. doi: 10.1007/s00384-022-04254-z. Epub 2022 Sep 23. PMID: 36149447 PMCID: PMC9560971 | S. Kneißl, J. Stallhofer, P. Schlattmann, A. Stallmach |
| Recurrent disseminated intravascular coagulation in metastatic castration-resistant prostate cancer: a case report. Diagnostics (Basel) 2022 Sep 28;12(10):2342. doi: 10.3390/diagnostics12102342, PMID: 36292031 PMCID: PMC9600388 | B. Giszas , M.Fritzenwanger, M.-O. Grimm, A. Stallmach, P. Reuken |
| Integration of ultrasonography training into undergraduate medical education: catch up with professional needs. nsights Imaging. 2022 Sep 24;13(1):150. doi: 10.1186/s13244-022-01296-3, PMID: 36153444 PMCID: PMC9509508 | Teichgräber U, Ingwersen M, Ehlers C, Mentzel HJ, Redies C, Stallmach A, Behringer W, Guntinas-Lichius O. |
| Clinical and surgical factors for successful stoma reversal in patients with Crohn's disease-results of a retrospective cohort study. Int Journal of colorectal disease, 2022 Oct;37(10):2237-2244. doi: 10.1007/s00384-022-04262-z. Epub 2022 Oct 3. PMID: 36190548 | Ludewig C, Jacob V, Stallmach A, Bruns T, Teich N |
| Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients. Crit Care. 2022 Sep 26;26(1):289. doi: 10.1186/s13054-022-04163-1. | Perez Ruiz de Garibay A, Kortgen A, Leonhardt J, Zipprich A, Bauer M |
| Evaluation of the definition of hyperdynamic circulation in patients with cirrhosis and ascites: Hepatol Commun. 2022 Dec;6(12):3528-3538. doi: 10.1002/hep4.2102. Epub 2022 Oct 11. PMID: 36221228 PMCID: PMC9701480 | Ripoll C, Ibáñez-Samaniego L, Neumann B, Vaquero J, Greinert R, Bañares R, Zipprich A |
| Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality. JHEP Rep 2021 Nov 3;4(1):100391. doi: 10.1016/j.jhepr.2021.100391. eCollection 2022 Jan PMID: 34917912 PMCID: PMC8666561 |
Reißing J, Lutz P, Frissen M, Ibidapo-Obe O, Reuken PA, Wirtz TH, Stengel S, Quickert S, Große K, Zimmermann HW, Trautwein C, Stallmach A, Bruns T |
| Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND randomized trial protocol. Future Oncol. 2022 Apr;18(12):1423-1435. doi: 10.2217/fon-2021-1261. Epub 2022 Jan 27. PMID: 35081747 | Ben Khaled N, Seidensticker M, Ricke J, Mayerle J, Oehrle B, Rössler D, Teupser D, Ehmer U, Bitzer M, Waldschmidt D, Fuchs M, Reuken PA, Lange C, Wege H, Kandulski A, Dechêne A, Venerito A, Berres ML, Luedde T, Kubisch I, Reiter FP, De Toni EN |
| A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - indications for their potential involvement in the development of Long COVID?. Front Immunol. 2022 Dec 13;13:1070994. doi: 10.3389/fimmu.2022.1070994. eCollection 2022. PMID: 36582234 PMCID: PMC9792979 | Haunhorst S, Bloch W, Javelle F, Krüger K, Baumgart S, Druber S, Lemhöfer C, Reuken PA, Stallmach A, Kamradt T, Pletz MW, Puta C |
| Sublcinical cognitive impairment in chronic kidney disease is associated to frailty and reduced quality of life. Nephrol Dial Transplant 2022 Nov 2:gfac303. doi: 10.1093/ndt/gfac303. | Greinert R, Greinert D, Eger AL, Ripoll C, Girndt M. |
| Reply to "Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma. J Hepatol 2022 Aug;77(2):567-568. doi: 10.1016/j.jhep.2022.04.029. Epub 2022 May 5. | de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C |
| Intestinal Wnt in the transition from physiology to oncology, World J Clin Oncol 2022 Mar 24;13(3):168-185. doi: 10.5306/wjco.v13.i3.168. | Julia Swoboda , Patrick Mittelsdorf , Yuan Chen , Ralf Weiskirchen , Johannes Stallhofer , Silke Schüle , Nikolaus Gassler |
| Suppression of MYC by PI3K/AKT/mTOR pathway inhibition in combination with all-trans retinoic acid treatment for therapeutic gain in acute myeloid leukaemia. Br J Haematol2022 Jul;198(2):338-348. doi: 10.1111/bjh.18187. Epub 2022 Apr 25 | Sven Stengel, Kevin R Petrie, Yordan Sbirkov, Clara Stanko, Faezeh Ghazvini Zadegan, Veronica Gil, Rafał Skopek, Paweł Kamiński, Łukasz Szymański, Annamaria Brioli, Arthur Zelent, Tino Schenk |
| Global PBC Study Group. Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid. Aliment Pharmacol Ther. 2022 Nov;56(9):1408-1418. doi: 10.1111/apt.17226. Epub 2022 Sep 22. PMID: 36138566; PMCID: PMC9826062. | de Veer RC, Harms MH, Corpechot C, Thorburn D, Invernizzi P, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Parés A, Mason AL, Kowdley KV, Trivedi PJ, Hirschfield GM, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Lammers WJ, Hansen BE, van Buuren HR, van der Meer AJ; |
| "Antibiotika assoziierte Diarrhoe" coloproctology 2022 44:389-394 | Lange K, Stallmach A |
Publikationen 2021
|
Balance of macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis. JHEP Rep. 2021 Apr; 3(2): 100221. |
Wirtz TH, Reuken PA, Jansen C, Fischer P, Bergmann I, Backhaus C, Emontzpohl,C, Reißing J, Brandt EF, Koenen MT, Schneider KM, Schierwagen R, Brol MJ, Chang,J, Zimmermann HW, Köse-Vogel N, Eggermann T, Kurth I, Stoppe C, Bucala R, Bernhagen J, Praktiknjo M, Stallmach A, Trautwein C, Trebicka J, Bruns T, Berres ML. |
|
Ruling out COVID-19 by chest CT at emergency admission to prevent in-hospital spread when prevalence is low – the prospective, observational SCOUT study. Respir Res. 2021 Jan 12;22(1):13 doi:10.1186/s12931-020-01611-w |
Teichgräber U, Malouhi A, Ingwersen M, Neumann R, Reljic M, Deinhardt-Emmer S, Löffler B, Behringer W, Lewejohann JC, Stallmach A, Reuken PA |
|
Safety of Tofacitinib in the COVID-19 pandemic - enough is not enough. Inflamm Bowel Dis. 2021 Jul 27;27(8):e89. |
Reuken PA, Teich N, Stallmach A |
|
Kryptosporidiose. |
Reuken PA |
|
Ein Jahr COVID-19 - Therapiemanagement im Krankenhaus. Ärzteblatt Thüringen 2021(10):18-20 |
Bauer M, Kortgen A, Reuken PA, Stallmach A |
|
"Ist Post-COVID die 4. Welle in unserem Gesundheitssystem? Erfahrungen aus der Post-COVID Ambulanz am Universitätsklinikum Jena". Ärzteblatt Thüringen 2021(10):21-23 |
Bauer M, Finke K, Heutelbeck A, Mutschke S, Pletz MW, Proquitté H, Quickert S, Reuken PA, Scherag A, Stallmach A, Vilser D, Walter M |
|
The immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality. JHEP Rep. 2021 Nov 3;4(1):100391. eCollection Jan 2022. doi: 10.1016/j.jhepr.2021.100391 |
Reißing J, Lutz P, Frissen M, Ibidapo-Obe O, Reuken PA, Wirtz TH, Stengel S, Quickert S, Rooney M. ,Große K, Zimmermann HW, Trautwein C, Stallmach A, Bruns T |
|
Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection. Leukemia. 2021 Mar;35(3):920-923. |
Reuken PA, Stallmach A, Pletz MW, Brandt C, Andreas N, Hahnfeld S, Löffler B, Baumgart S, Kamradt T, Bauer M |
|
Drug-induced Acute Pancreatitis - Anecdotal Evidence versus prospective Evaluation. Gastroenterology. 2021 Jun;160(7):2627-2628 |
Teich N, Bruns T, Stallmach A. |
|
Post-COVID chronic fatigue is frequent and not only restricted to hospitalized patients. Crit Care Med. 2021 Oct 1;49(10):e1052-e1053 doi: 10.1097/CCM.0000000000005122 |
Reuken PA, Scherag A, Stallmach A |
|
Greenspace in Childhood: A New Avenue to Prevent Inflammatory Bowel Disease? Am J Gastroenterol 2021 Sep 1;116(9):1964-1965. |
Teich A, Stallmach A, Bruns T |
|
Microbiota-based markers predictive of development of Clostridioides difficile infection. Nat Comm 2021 Apr 14;12(1):2241. doi: 10.1038/s41467-021-22302-0. |
Berkell M, Mysara M, Xavier BB, van Werkhoven CH, Monsieurs P, Lammens C, Ducher A, Vehreschild MJGT, Goossens H, de Gunzburg J, Bonten MJM, Malhotra-Kumar S; |
|
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease. New Engl J Med 2021 Jul 1;385(1):35-45. doi: 10.1056/NEJMoa2032441. |
Schuppan D, Mäki M, Lundin KEA, Isola J, Friesing-Sosnik T, Taavela J, Popp A, Koskenpato J, Langhorst J, Hovde Ø, Lähdeaho ML, Fusco S, Schumann M, Török HP, Kupcinskas J, Zopf Y, Lohse AW, Scheinin M, Kull K, Biedermann L, Byrnes V, Stallmach A, Jahnsen J, Zeitz J, Mohrbacher R, Greinwald R; CEC-3 Trial Group. Collaborator: Grunert PC, Stallhofer J |
|
Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome. |
Bojarski C, Tangermann P, Barmeyer C, Buchkremer J, Kiesslich R, Ellrichmann M, Schreiber S, Schmidt C, Stallmach A, Roehle R, Loddenkemper C, Daum S, Siegmund B, Schumann M, Ullrich R. |
|
Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study). |
Engelmann C, Herber A, Franke A, Bruns T, Reuken PA, Schiefke I, Zipprich A, Zeuzem S, Goeser T, Canbay A, Berg C, Trebicka J, Uschner FE, Chang J, Mueller T, Aehling N, Schmelzle M, Splith K, Lammert F, Lange CM, Sarrazin C, Trautwein C, Manns M, Häussinger D, Pfeiffenberger J, Galle PR, Schmiedeknecht A, Berg T. |
|
Acceptance of SARS-CoV-2 vaccines by German liver transplant recipients and candidates. Z Gastroenterol. 2021 Dec;59(12):1288-1296 doi:10.1055/a-1649-8568 |
Reuken PA, Albers S, Rauchfuss F, Strnad P, Settmacher U, Trautwein C, Stallmach A, Bruns T |
|
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey. Lancet Reg Health Eur. 2021 Jul 19;9:100181. |
Baunwall SMD, Terveer EM, Dahlerup JF, Erikstrup C, Arkkila P, Vehreschild MJ, Ianiro G, Gasbarrini A, Sokol H, Kump PK, Satokari R, De Looze D, Vermeire S, Nakov R, Brezina J, Helms M, Kjeldsen J, Rode AA, Kousgaard SJ, Alric L, Trang-Poisson C, Scanzi J, Link A, Stallmach A, Kupcinskas J, Johnsen PH, Garborg K, Rodríguez ES, Serrander L, Brummer RJ, Galpérine KT, Goldenberg SD, Mullish BH, Williams HR, Iqbal TH, Ponsioen C, Kuijper EJ, Cammarota G, Keller JJ, Hvas CL |
|
Eine chirurgisch relevante Zusammenfassung des Addendums zu den DGVS-S3-Leitlinien Morbus Crohn und Colitis ulcerosa. Chirurg 92, 30–33 (2021) |
Grunert PC, Dignass A, Kucharzik T, Stallmach A, Sturm A, Schmidt C |
|
Mineralocorticoid receptor in non-alcoholic fatty liver disease. |
Schreier B, Zipprich A, Uhlenhaut H, Gekle M. |
|
First things first! Can bacterial infections be considered as decompensating events per se? |
Reichert MC, Ripoll C |
|
[Cirrhosis]. |
Zipprich A, Ripoll C |
|
Isolated bacterial infection without decompensation has no impact on survival of compensated patients with cirrhosis. |
Reichert MC, Schneider C, Greinert R, Casper M, Grünhage F, Wienke A, Zipprich A, Lammert F, Ripoll C |
|
Medikamentöse Therapie chronisch-entzündlicher Darme-rkrankungen – Was muss der Chirurg wissen und perioperativ beachten? [Drug treatment of chronic inflammatory bowel diseases-What must the surgeon know and perioperatively pay attention to?]. Chirurg. 2021 Jan;92(1):3-11. German. doi: 10.1007/s00104-020-01305-5. |
Lange K, Stallmach A |
|
Appendectomy in childhood-did it save my sibling from getting ulcerative colitis? Int J Colorectal Dis. 2021 Mar;36(3):623-624. doi: 10.1007/s00384-020-03780-y. Epub 2020 Oct 23. |
Teich N, Bruns T, Stallmach A |
|
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy. J Hepatol. 2021 Apr;74(4):801-810. doi: 10.1016/j.jhep.2020.11.017. Epub 2020 Nov 19. |
Dietz J, Di Maio VC, de Salazar A, Merino D, Vermehren J, Paolucci S, Kremer AE, Lara M, Pardo MR, Zoller H, Degasperi E, Peiffer KH, Sighinolfi L, Téllez F, Graf C, Ghisetti V, Schreiber J, Fernández-Fuertes E, Boglione L, Muñoz-Medina L, Stauber R, Gennari W, Figueruela B, Santos J, Lampertico P, Zeuzem S, Ceccherini-Silberstein F, García F, Sarrazin C |
|
Post-Test Probability of COVID-19 Using CT. |
Teichgräber T, Behringer W , Stallmach A |
|
Clinical effectiveness of bidirectional fecal microbiota transfer in the treatment of recurrent Clostridioides difficile infections. |
Bestfater C, Vehreschild MJGT, Stallmach A, Tüffers K, Erhardt A, Frank T, Glück T, Goeser F, Sellge G, Solbach P, Eisenlohr H, Storr M; German Clinical Microbiome Study Group (GCMSG). |
|
Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection. |
Reuken PA, Stallmach A, Pletz MW, Brandt C, Andreas N, Hahnfeld S, Löffler B, Baumgart S, Kamradt T, Bauer M. |
|
Prospective surveillance study in a 1,400-bed university hospital: COVID-19 exposure at home was the main risk factor for SARS-CoV-2 point seroprevalence among hospital staff. |
Bahrs C, Kimmig A, Weis S, Ankert J, Hagel S, Maschmann J, Stallmach A, Steiner A, Bauer M, Behringer W, Baier M, Kesselmeier M, Richert C, Zepf F, Walter M, Scherag A, Kiehntopf M, Löffler B, Pletz MW |
|
The COVID-19 Pandemic: Fears and Overprotection in Pediatric Patients with Inflammatory Bowel Disease and Their Families. Pediatr Gastroenterol Hepatol Nutr. 2021 Jan;24(1):65-74. doi: 10.5223/pghn.2021.24.1.65 |
Reinsch S, Stallmach A, Grunert PC |
|
Nondestructive molecular imaging by Raman spectroscopy vs. marker detection by MALDI IMS for an early diagnosis of HCC Analyst. 2021 Feb 21;146(4):1239-1252. doi: 10.1039/d0an01555e. Epub 2020 Dec 14 |
Kirchberger-Tolstik T, Ryabchykov O , Bocklitz T , Dirsch O , Settmacher U , Popp J , Stallmach A |
|
Primed circulating monocytes are a source of IL-1β in patients with cirrhosis and ascites. Gut. 2021 Mar;70(3):622-623. doi: 10.1136/gutjnl-2020-321597. Epub 2020 Jun 22 |
Stengel S, Steube A, Köse-Vogel N, Kirchberger-Tolstik T, Deshmukh S, Bruns T |
|
An Update for Pharmacologists on New Treatment Options for Inflammatory Bowel Disease: The Clinicians' Perspective. |
Schmidt C, Grunert PC, Stallmach A |
|
Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics. Nat Commun. 2021 Apr 14;12(1):2240. doi: 10.1038/s41467-021-22269-y. |
van Werkhoven CH, Ducher A, Berkell M, Mysara M, Lammens C, Torre-Cisneros J, Rodríguez-Baño J, Herghea D, Cornely OA, Biehl LM, Bernard L, Dominguez-Luzon MA, Maraki S, Barraud O, Nica M, Jazmati N, Sablier-Gallis F, de Gunzburg J, Mentré F, Malhotra-Kumar S, Bonten MJM, Vehreschild MJGT |
|
Effect of Originator Infliximab Treatment on Disease-Related Hospitalizations, Work Productivity and Activity Impairment, and Health Resource Utilization in Patients with Crohn's Disease in a Real-Life Setting: Results of a Prospective Multicenter Study in Germany. Inflamm Intest Dis. 2021 Feb;6(1):48-60 |
Teich N, Bläker M, Holtkamp-Endemann F, Jörgensen E, Stallmach A, Hohenberger S. |
|
Auswirkungen einer SARS-CoV-2-Infektion auf Symptomatik und Therapie chronisch-entzündlicher Darmerkrankungen [Effects of SARS-CoV-2 Infection on Symptoms and Therapy of Inflammatory Bowel Disease]. Z Gastroenterol. 2021 Nov;59(11):1189-1196. German. doi: 10.1055/a-1508-6734. Epub 2021 Jul 16. |
Teich N, Ludewig C, Schmelz R, Bästlein E C, Geißler S, Nagl S, Walldorf J, Krause T, Maaser C, Mohl W, Wedemeyer H H, Bauer T, Büning C, Grunert PC, Hasselblatt P, Hänßchen M, Kahl M, Engelke O,Schubert S, Holler B, Streetz K, von Arnim U, Schmidt K, Stallmach A für die German IBD Study Group |
|
SARS-CoV-2 vaccination in patients with inflammatory bowel disease – fear and desire. Z Gastroenterol. 2021 Nov;59(11):1189-1196 |
Walldorf J, von Arnim U, Schmelz R, Riesner-Wehner A, Michl A, Grunert PC, Stallmach A, Teich N, Reuken PA |
|
Computational tissue staining of non-linear multimodal imaging using upervised and unsupervised deep learning. |
Pradhan P, Meyer T, Vieth M, Stallmach A, Waldner M, Schmitt M, Popp J, Bocklitz T. |
|
Yoghurt-induced Lactobacillus bacteremia in a patient with Crohn's disease on therapy with ustekinumab and concomitant HIV-Infection. Z Gastroenterol. 2021 Apr;59(4):317-320 |
Haziri D, Prechter F, Stallmach A |
|
T cell response after SARS-CoV-2 vaccination in immunocompromised patients with inflammatory bowel disease. JCC, 2021 Aug 11:jjab147. doi: 10.1093/ecco-jcc/jjab147. |
Reuken PA, Andreas N, Grunert PC, Glöckner S, Kamradt T, Stallmach A |
|
Recurrent upper gastrointestinal bleeding from isolated gastric varices as primary symptom of myelofibrosis - a case report on combining interventional and pharmacologic treatment options Dig Dis, 2021 Aug 2. doi: 10.1159/000518766. Online ahead of print. |
Giszas B, Weber M, Heidel FH, Reuken PA |
|
S1-Leitlinie-Post-COVID/Long-COVID [S1 Guideline Post-COVID/Long-COVID]. Pneumologie. 2021,Nov;75(11):869-900 |
Koczulla AR, Ankermann T, Behrends U, Berlit P, Böing S, Brinkmann F, Franke C, Glöckl R, Gogoll C, Hummel T, Kronsbein J, Maibaum T, Peters EMJ, Pfeifer M, Platz T, Pletz M, Pongratz G, Powitz F, Rabe KF, Scheibenbogen C, Stallmach A, Stegbauer M, Wagner HO, Waller C, Wirtz H, Zeiher A, Zwick RH |
|
Long-/Post-COVID – Wenn das Virus Spuren hinterlässt - eine klinische Übersicht für Behandelnde, basierend auf der aktuellen S1 Leitlinie. Deutsches Ärzteblatt Int, 2021, 118(39):A-1762/B-1459 |
Koczulla AR, Glöckl R, Peters EMJ, Rabe KF, Stallmach A, Gogoll C |
|
Clinical characteristics and outcome of patients with enterococcal liver abscess. Scientific Reports 2021 Nov 15;11(1):22265. doi:10.1038/s41598-021-01620-9. |
Große K, Ohm D, Würstle S, Brozat JF, Schmid RM, Trautwein C, Stallmach A, Bruns T, Reuken PA |
|
Results from the German registry for refractory celiac disease. |
Weber M, Wolf N, Branchi F, Tangermann P, Itzlinger A, Poralla L, Preiß JC, Grunert P, Daum S, Siegmund B, Stallmach A, Schumann M |
|
The impact of specific cytokine directed treatment on severe COVID-19. Leukemia, 2021 Dec;35(12):3613-3615. doi: |
Reuken PA, Rüthrich MM, Hochhaus A, Hammersen J, Bauer M, La Rosée P, La Rosée F, Stallmach A |
|
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure, J Hepatol. 2021 Feb;74(2):330-339. doi: 10.1016/j.jhep.2020.07.046. Epub 2020 Aug 8. |
Wong F, Piano S, Singh V, Bartoletti M, Maiwall R, Alessandria C, Fernandez J, Soares EC, Kim DJ, Kim SE, Marino M, Vorobioff J, Barea RCR, Merli M, Elkrief L, Vargas V, Krag A, Singh SP, Lesmana LA, Toledo C, Marciano S, Verhelst X, Intagliata N, Rabinowich L, Colombato L, Kim SG, Gerbes A, Durand F, Roblero JP, Bruns T, Yoon EL, Girala M, Pyrsopoulos NT, Kim TH, Yim SY, Juanola A, Gadano A, Angeli P |
|
A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis, Am J Gastroenterol. 2021 Jul 1;116(7):1514-1522. doi: 10.14309/ajg.0000000000001285 |
Goet JC, Murillo Perez CF, Harms MH, Floreani A, Cazzagon N, Bruns T, Prechter F, Dalekos GN, Verhelst X, Gatselis NK, Lindor KD, Lammers WJ, Gulamhusein A, Reig A, Carbone M, Nevens F, Hirschfield GM, van der Meer AJ, van Buuren HR, Hansen BE, Parés A |
|
Reply to: "G-CSF in acute-on-chronic liver failure - Art of 'patient selection' is paramount!", J Hepatol. 2022 Feb;76(2):473-475. doi: 10.1016/j.jhep.2021.10.019. Epub 2021 Oct 29. |
Engelmann C, Bruns T, Berg T |
|
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool, Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e266-e273. doi: 10.1097/MEG.0000000000002029. |
Murillo Perez CF, Gulamhusein A, Carbone M, Trivedi PJ, van der Meer AJ, Corpechot C, Battezzati PM, Lammers WJ, Cazzagon N, Floreani A, Parés A, Nevens F, Lleo A, Mayo MJ, Kowdley KV, Ponsioen CY, Dalekos GN, Gatselis NK, Thorburn D, Mason AL, Janssen H, Verhelst X, Bruns T, Lindor KD, Chazouillères O, Invernizzi P, Hansen BE, Hirschfield GM |
|
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled |
Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ; |